Axogen, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AXGN | BVS | ARX.AX | ATEC | AORT | CNMD | |
|---|---|---|---|---|---|---|
| Market cap | 3.07B | 781.98M | 171.82M | 1.27B | 1.29B | 1.60B |
| P/E (TTM) | — | 14.1 | 49.0 | — | — | 22.3 |
| Forward P/E | 72.8 | 12.5 | 16.8 | 14.7 | 35.3 | 11.3 |
| Price/book | 6.2 | 3.3 | 2.1 | -552.0 | 2.9 | 1.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +114.05% | +52.67% | −38.22% | −62.12% | −44.32% | +21.38% |
| Today | +3.74% | +4.34% | +1.03% | +10.84% | +11.56% | +13.61% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.
Latest news
All AXGN news ›AxoGen (NASDAQ:AXGN) Upgraded at Wall Street Zen
Posted by Sarita Garza on Nov 3rd, 2026 Wall Street Zen upgraded shares of AxoGen (NASDAQ:AXGN – Free Report) from a hold rating to a strong-buy rating in a research report released on Saturday morning,Wall Street Zen reports. View Our…
Axogen: Taking The Friction Out Of Nerve Repair
Axogen (AXGN) is evolving from a growth story to the default procedural platform in peripheral nerve repair, protected by a regulatory moat for the next... - Axogen (AXGN) is evolving from a growth story to the default procedural platform…
AxoGen (NASDAQ:AXGN) Stock Price Target Raised at HC Wainwright
Posted by Defense World Staff on Oct 30th, 2026 AxoGen (NASDAQ:AXGN – Free Report) had its price objective lifted by HC Wainwright from $53.00 to $56.00 in a report issued on Thursday, Marketbeat reports. The firm currently has a buy…
Axogen Q3 2026: Earnings Beat Expectations and Guidance Raised to $290M
As seen on the 24/7 Wall St. homepage on October 28, 2026. Axogen raised full-year revenue guidance to at least $290 million after nerve repair demand drove a double beat. Management is targeting a prostate market entry in 2027. Axogen…
Axogen forecasts at least $290M 2026 revenue, adds $7M from BioCircuit while planning prostate market development in 2027
Axogen Q3 2026 earnings: revenue jumped 26%, guidance rose to $290M, and BioCircuit adds NerveTape growth potential. Earnings Call Insights: Axogen (AXGN) Q3 2026 - "Third quarter revenue was $75.8 million, up 26.2% from third quarter…
Axogen, Inc. Reports Third Quarter 2026 Financial Results
--Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today reported financial results and business highlights for the third quarter ended September 30,…
More from 1 other outlet
Axogen Stock Soars 22% as Nerve Repair Company Posts 26% Sales Jump, Raises 2026 Outlook After BioCircuit Deal
Shares of Axogen Inc. jumped nearly 22% on Wednesday. The nerve repair company reported third-quarter results that beat Wall Street's expectations and raised its full-year sales forecast after completing an acquisition. Axogen shares rose…
Analyzing AxoGen (NASDAQ:AXGN) & RxSight (NASDAQ:RXST)
Posted by Danessa Lincoln on Oct 22nd, 2026 AxoGen (NASDAQ:AXGN – Get Free Report) and RxSight (NASDAQ:RXST – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses…
Weekly Research Analysts’ Ratings Changes for AxoGen (AXGN)
A number of firms have modified their ratings and price targets on shares of AxoGen (NASDAQ: AXGN) recently: 10/12/2026 – AxoGen is now covered by Bank of America Corporation. They set a “buy” rating and a $52.00 price target on the stock.…
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY) and AxoGen (AXGN)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bristol-Myers Squibb (BMY) and AxoGen (AXGN). BMO Capital analyst Evan Seigerman maintained a Hold rating on Bristol-Myers Squibb today and…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com6
- themarketsdaily.com3
- defenseworld.net2
- 247wallst.com1
- aaii.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.